Negative regulation of Rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: Role of nitric oxide and cyclic guanosine monophosphate signaling pathways

Diabetes

Volumn 51, Issue 7, 2002, Pages 2256-2263

  Begum, Najma ^a,b   Sandu, Oana A ^a   Duddy, Noreen ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; ACTIN; CYCLIC GMP; GLUTATHIONE TRANSFERASE; INSULIN; NITRIC OXIDE; PHENYLEPHRINE; RHO KINASE; THROMBIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONAL REGULATION; HORMONE ACTION; IMMUNOPRECIPITATION; ISOPRENYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0036302962     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.7.2256     Document Type: Article

References (33)

1. Regulation of Rho proteins
2. Rho as a mediator of G proteincoupled receptor signaling
3. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells
4. Pharmacomechanical coupling and the role of calcium, G-proteins, kinases and phosphatases
5. Role of guanine nucleotide-binding proteins-ras-family or trimeric proteins or both-in Ca2+ sensitization of smooth muscle
6. The Rho-related protein Rndl inhibits Ca2+: Sensitization of rat smooth muscle
7. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho kinase)
8. Rho-associated kinase dir Signal transduction and regulation in smooth muscle directly induces smooth muscle contraction through myosin light chain phosphorylation
9. Signal transduction and regulation in smooth muscle
10. cGMP causes Ca2+ desensitization in vascular smooth muscle cells by activating the myosin light chain phosphatase
11. Differential translocation of Rho family GTPases by lysophosphatidic acid, endothelin-1, and platelet-derived growth factor
12. Translocation of rhoA associated with Ca2+ sensitization of smooth muscle
13. Mammalian protein geranylgeranyltransferase: Subunit composition and metal requirements
14. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro
15. Cyclic GMP-dependent: Protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle
16. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding
17. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: An update
18. Insulin signaling in the arterial wall
19. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase'in hypertension
20. Diabetes is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooh muscle cell relaxation due to defective Rho kinase and NOS signaling
21. Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: Evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase dependent signaling pathways
22. Regulation of MKP-1 expression by insulin in vascular smooth muscle cells: Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension
23. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension
24. High glucose and chronic insulin inhibit MKP-1 expression in VSMCs by blocking iNOS induction via p38 MAPK activation Am
25. Simultaneous localization and quantification of relative G and F actin content: Optimization of fluorescence labeling methods
26. Sequence dependence of protein isoprenylation
27. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells
28. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase
29. Rho as a mediator of G protein-coupled receptor signaling
30. Phosphorylation of the large regulatory subunit of myosin phosphatase and inhibition of phosphatase activity
31. P2Y1, P2Y2, P2Y4, and P2Y6 receptors are coupled to Rho and Rho kinase activation in vascular myocytes
32. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells
33. Roles for insulin receptor, P13-kinase, and Akt in insulin-signaling pathways related to production of NO in human vascular endothelial cells